BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30882647)

  • 1. Single nucleotide polymorphism of rs2596542 and the risk of hepatocellular carcinoma development: A meta-analysis.
    Kuang XJ; Mo DC; Qin Y; Ahir BK; Wang JJ; Peng Z; Deng ZL
    Medicine (Baltimore); 2019 Mar; 98(11):e14767. PubMed ID: 30882647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.
    Luo X; Wang Y; Shen A; Deng H; Ye M
    BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients.
    Marangon CG; de Bitencorte JT; Michita RT; Lunge VR; Dos Santos DC; Álvares-da-Silva MR; Simon D
    Pathol Oncol Res; 2020 Jul; 26(3):1519-1525. PubMed ID: 31471884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction Between Polymorphisms of IFN-γ and MICA Correlated with Hepatocellular Carcinoma.
    Li H; Liu F; Zhu H; Zhou X; Lu J; Chang H; Hu J
    Med Sci Monit; 2016 Feb; 22():549-53. PubMed ID: 26893439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNP rs2596542G>A in MICA is associated with risk of hepatocellular carcinoma: a meta-analysis.
    Wang H; Cao H; Xu Z; Wang D; Zeng Y
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30967497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma.
    Lange CM; Bibert S; Dufour JF; Cellerai C; Cerny A; Heim MH; Kaiser L; Malinverni R; Müllhaupt B; Negro F; Semela D; Moradpour D; Kutalik Z; Bochud PY;
    J Hepatol; 2013 Sep; 59(3):504-9. PubMed ID: 23665287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample.
    Augello G; Balasus D; Fusilli C; Mazza T; Emma MR; Giannitrapani L; Agliastro R; Cervello M; Montalto G
    OMICS; 2018 Apr; 22(4):274-282. PubMed ID: 29584564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.
    Kumar V; Yi Lo PH; Sawai H; Kato N; Takahashi A; Deng Z; Urabe Y; Mbarek H; Tokunaga K; Tanaka Y; Sugiyama M; Mizokami M; Muroyama R; Tateishi R; Omata M; Koike K; Tanikawa C; Kamatani N; Kubo M; Nakamura Y; Matsuda K
    PLoS One; 2012; 7(9):e44743. PubMed ID: 23024757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk.
    Lo PH; Urabe Y; Kumar V; Tanikawa C; Koike K; Kato N; Miki D; Chayama K; Kubo M; Nakamura Y; Matsuda K
    PLoS One; 2013; 8(4):e61279. PubMed ID: 23593449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection.
    Huang CF; Wang SC; Chang WT; Yeh ML; Huang CI; Lin ZY; Chen SC; Chuang WL; Huang JF; Dai CY; Chen YL; Yu ML
    Sci Rep; 2018 Oct; 8(1):15821. PubMed ID: 30361527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication.
    Huang CF; Wang SC; Yeh ML; Huang CI; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Chen A; Yu ML
    J Gastroenterol Hepatol; 2019 Jan; 34(1):249-255. PubMed ID: 29932235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients.
    Al-Qahtani AA; Al-Anazi M; Abdo AA; Sanai FM; Al-Hamoudi W; Alswat KA; Al-Ashgar HI; Khalaf N; Viswan N; Al-Ahdal MN
    Exp Mol Pathol; 2013 Dec; 95(3):255-8. PubMed ID: 23994040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma.
    Zhong JH; Xiang BD; Ma L; You XM; Li LQ; Xie GS
    PLoS One; 2013; 8(2):e57064. PubMed ID: 23451147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma.
    Hai H; Tamori A; Thuy LTT; Yoshida K; Hagihara A; Kawamura E; Uchida-Kobayashi S; Morikawa H; Enomoto M; Murakami Y; Kawada N
    Sci Rep; 2017 Sep; 7(1):11912. PubMed ID: 28928439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment.
    Huang CF; Huang CY; Yeh ML; Wang SC; Chen KY; Ko YM; Lin CC; Tsai YS; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML
    EBioMedicine; 2017 Feb; 15():81-89. PubMed ID: 27998720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis.
    Zhong JH; You XM; Gong WF; Ma L; Zhang Y; Mo QG; Wu LC; Xiao J; Li LQ
    PLoS One; 2012; 7(3):e32159. PubMed ID: 22403631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
    Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
    J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association between miR-146a single nucleotide polymorphism and genetic susceptibility to hepatocellular carcinoma: a meta-analysis].
    Zhang LH; Zhang CY; Dai XZ; Zhang J; Zhang F
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):749-754. PubMed ID: 29108203
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF; Zheng EQ; Xie M
    Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of SNP (rs2596542) in histocompatibility complex class I-related gene A promoter region among hepatitis C virus related hepatocellular carcinoma cases.
    Mohamed AA; Elsaid OM; Amer EA; Elosaily HH; Sleem MI; Gerges SS; Saleh MA; El Shimy A; El Abd YS
    J Adv Res; 2017 Jul; 8(4):343-349. PubMed ID: 28417047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.